BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19224633)

  • 1. Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects.
    Struyf S; Proost P; Vandercappellen J; Dempe S; Noyens B; Nelissen S; Gouwy M; Locati M; Opdenakker G; Dinsart C; Van Damme J
    Eur J Immunol; 2009 Mar; 39(3):843-57. PubMed ID: 19224633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin.
    Boyd JH; Divangahi M; Yahiaoui L; Gvozdic D; Qureshi S; Petrof BJ
    Infect Immun; 2006 Dec; 74(12):6829-38. PubMed ID: 16982839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma.
    Penton-Rol G; Polentarutti N; Luini W; Borsatti A; Mancinelli R; Sica A; Sozzani S; Mantovani A
    J Immunol; 1998 Apr; 160(8):3869-73. PubMed ID: 9558092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
    Proost P; Struyf S; Couvreur M; Lenaerts JP; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J
    J Immunol; 1998 Apr; 160(8):4034-41. PubMed ID: 9558113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
    Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
    J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
    Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
    BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1.
    Sozzani S; Zhou D; Locati M; Rieppi M; Proost P; Magazin M; Vita N; van Damme J; Mantovani A
    J Immunol; 1994 Apr; 152(7):3615-22. PubMed ID: 8144937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    J Periodontal Res; 2008 Aug; 43(4):471-7. PubMed ID: 18557811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2.
    O'Boyle G; Brain JG; Kirby JA; Ali S
    Mol Immunol; 2007 Mar; 44(8):1944-53. PubMed ID: 17081610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression.
    Bonfield TL; John N; Malur A; Barna BP; Culver DA; Kavuru MS; Thomassen MJ
    Clin Immunol; 2005 Jan; 114(1):79-85. PubMed ID: 15596412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen selectively regulates chemokines in murine splenocytes.
    Lengi AJ; Phillips RA; Karpuzoglu E; Ahmed SA
    J Leukoc Biol; 2007 Apr; 81(4):1065-74. PubMed ID: 17185357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
    Van Damme J; Proost P; Put W; Arens S; Lenaerts JP; Conings R; Opdenakker G; Heremans H; Billiau A
    J Immunol; 1994 Jun; 152(11):5495-502. PubMed ID: 8189067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
    Kim B; Sarangi PP; Lee Y; Deshpande Kaistha S; Lee S; Rouse BT
    J Leukoc Biol; 2006 Dec; 80(6):1405-15. PubMed ID: 16997857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes.
    Sakai N; Wada T; Furuichi K; Shimizu K; Kokubo S; Hara A; Yamahana J; Okumura T; Matsushima K; Yokoyama H; Kaneko S
    J Leukoc Biol; 2006 Mar; 79(3):555-63. PubMed ID: 16415174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells.
    Frade JM; Mellado M; del Real G; Gutierrez-Ramos JC; Lind P; Martinez-A C
    J Immunol; 1997 Dec; 159(11):5576-84. PubMed ID: 9548499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
    Parody TR; Stone MJ
    Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands.
    Pierer M; Rethage J; Seibl R; Lauener R; Brentano F; Wagner U; Hantzschel H; Michel BA; Gay RE; Gay S; Kyburz D
    J Immunol; 2004 Jan; 172(2):1256-65. PubMed ID: 14707104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha.
    Gaga M; Ong YE; Benyahia F; Aizen M; Barkans J; Kay AB
    Allergy; 2008 Jun; 63(6):703-11. PubMed ID: 18070228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
    J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.